Related Experiment Video

Updated: Dec 14, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K

Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions

Zbigniew Siudak1, Marek Grygier2, Wojciech Wojakowski3

  • 1Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|July 21, 2020
PubMed

Insights

The COVID-19 pandemic reduced percutaneous coronary interventions in Poland, shifting procedures towards acute cases. Patients with COVID-19 undergoing these interventions had similar outcomes to those without the virus.

Area of Science:

  • Cardiology
  • Public Health
  • Infectious Diseases

Background:

  • The COVID-19 pandemic has strained global healthcare systems, impacting resources for non-COVID-19 patients.
  • This study investigates the effects of the SARS-CoV-2 pandemic and national lockdown on percutaneous coronary treatments in Poland.

Purpose of the Study:

  • To assess the impact of the SARS-CoV-2 pandemic on percutaneous coronary interventions (PCI) in Poland.
  • To compare PCI procedures during the initial lockdown period (March 13-May 13, 2020) with the same period in 2019.

Main Methods:

  • Data from a national PCI database (ORPKI Registry) were analyzed for March 13-May 13, 2020.
  • Procedures were compared to the analogous period in 2019.
  • Cardiac catheterization center closures and physician infections due to SARS-CoV-2 were recorded.

Main Results:

  • 15.2% of cardiac catheterization centers closed; 1.7% of interventional cardiologists were infected with SARS-CoV-2.
  • A total of 13,750 interventional cardiology procedures were performed.
  • There was a significant shift towards acute coronary syndrome procedures (66%) compared to 2019 (50%), alongside an overall reduction in procedures. 362 patients (2.6%) with confirmed/suspected COVID-19 were treated, including 145 with STEMI (6% of all STEMIs).

Conclusions:

  • The SARS-CoV-2 pandemic led to a reduction in both acute and elective interventional procedures, with a notable increase in the proportion of acute cases.
  • COVID-19 patients treated with PCI exhibited similar procedural characteristics, baseline profiles, and outcomes compared to non-COVID-19 patients.
Abstract

Keywords:
COVID-19acute coronary syndromeinterventional cardiology

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

418

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
749
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
144
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
196
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
164
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
278
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
518